Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0400
-0.0020 (-4.76%)
Oct 6, 2025, 1:40 PM NZST
Rua Bioscience Cash Flow Statement
Financials in millions NZD. Fiscal year is July - June.
Millions NZD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2019 - 2020 |
Net Income | -3.46 | -13.72 | -5.96 | -8.64 | -4.42 | Upgrade |
Depreciation & Amortization | 0.4 | 0.4 | 0.68 | 0.81 | 0.69 | Upgrade |
Loss (Gain) From Sale of Assets | -0.07 | -0 | 0.01 | -0 | 0 | Upgrade |
Asset Writedown & Restructuring Costs | 0.04 | 9.21 | 5.57 | - | - | Upgrade |
Stock-Based Compensation | 0.04 | 0.37 | 0.09 | -0.14 | 0.54 | Upgrade |
Other Operating Activities | 0.15 | -0.11 | -6 | 1.07 | -1.84 | Upgrade |
Change in Accounts Receivable | -0.05 | 0.59 | -0.29 | 0.1 | 0.37 | Upgrade |
Change in Inventory | -0.05 | -0.26 | 0.15 | -0.24 | - | Upgrade |
Change in Accounts Payable | 0.19 | 0.03 | 0.09 | 0 | 0.26 | Upgrade |
Change in Unearned Revenue | -0.07 | 0.06 | 0 | 0.01 | -0.09 | Upgrade |
Change in Other Net Operating Assets | 0.08 | -0.31 | -0.28 | 0.17 | 0.04 | Upgrade |
Operating Cash Flow | -2.79 | -3.74 | -5.92 | -6.84 | -4.45 | Upgrade |
Capital Expenditures | -0 | -0 | -0.07 | -0.4 | -1.4 | Upgrade |
Sale of Property, Plant & Equipment | 0.11 | 0.05 | 0.03 | 0 | 0.02 | Upgrade |
Cash Acquisitions | - | - | - | 0.88 | - | Upgrade |
Investment in Securities | - | 2 | 6 | 5 | -13.12 | Upgrade |
Other Investing Activities | 0 | 0.16 | 0.71 | 0.11 | 0.07 | Upgrade |
Investing Cash Flow | 0.11 | 2.21 | 6.67 | 5.59 | -14.43 | Upgrade |
Short-Term Debt Issued | 1.29 | - | - | - | - | Upgrade |
Total Debt Issued | 1.29 | - | - | - | - | Upgrade |
Short-Term Debt Repaid | -0.69 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | -0.08 | -0.08 | -0.1 | -0.16 | -0.16 | Upgrade |
Total Debt Repaid | -0.77 | -0.08 | -0.1 | -0.16 | -0.16 | Upgrade |
Net Debt Issued (Repaid) | 0.51 | -0.08 | -0.1 | -0.16 | -0.16 | Upgrade |
Issuance of Common Stock | 1.68 | - | - | - | 20 | Upgrade |
Other Financing Activities | -0.18 | -0.02 | -0.02 | -0.04 | -1.54 | Upgrade |
Financing Cash Flow | 2.02 | -0.09 | -0.12 | -0.21 | 18.3 | Upgrade |
Foreign Exchange Rate Adjustments | 0.01 | -0.01 | - | - | - | Upgrade |
Net Cash Flow | -0.65 | -1.63 | 0.63 | -1.46 | -0.58 | Upgrade |
Free Cash Flow | -2.79 | -3.74 | -5.99 | -7.25 | -5.85 | Upgrade |
Free Cash Flow Margin | -152.79% | -1181.50% | -896.65% | -1123.09% | -1627.85% | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.02 | -0.04 | -0.05 | -0.05 | Upgrade |
Cash Interest Paid | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | Upgrade |
Levered Free Cash Flow | -1.62 | -2.9 | -6.93 | -1.53 | -3.71 | Upgrade |
Unlevered Free Cash Flow | -1.52 | -2.89 | -6.92 | -1.5 | -3.69 | Upgrade |
Change in Working Capital | 0.1 | 0.11 | -0.32 | 0.05 | 0.57 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.